Duloxetine vs. Active Comparator for the Treatment of Depression
Status and phase
Completed
Phase 4
Conditions
Depression
Treatments
Drug: Duloxetine Hydrochloride
Drug: Venlafaxine Extended Release
Details and patient eligibility
About
How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder.
The safety of duloxetine and any side effects that might be associated with it.
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- must be at least 18 years of age
- must be diagnosed with depression
- must sign informed consent
Exclusion criteria
- women who can become pregnant must be using birth control
- previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder
- history of substance abuse or dependence in the last year
- patients who are suicidal
- frequent or severe allergic reactions with multiple medications
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
Double Blind
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems